What is Tango Therapeutics's accrued manufacturing costs?

Tango Therapeutics (TNGX) reported accrued manufacturing costs of $3.24M in Q1 2026.

How has Tango Therapeutics's accrued manufacturing costs changed year-over-year?

Tango Therapeutics's accrued manufacturing costs increased by 1.9% year-over-year, from $3.18M to $3.24M.

What is the long-term trend for Tango Therapeutics's accrued manufacturing costs?

Over 5 years (2020 to 2025), Tango Therapeutics's accrued manufacturing costs has grown at a 27.8% compound annual growth rate (CAGR), from $2.65M to $9.05M.

Tango Therapeutics TNGX Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Lantheus HoldingsLNTH

——

Tempus AI, Inc.TEM

——

Roivant SciencesROIV

——

IncyteINCY

——

Eli LillyLLY

——

ModernaMRNA

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's accrued manufacturing costs?: Tango Therapeutics (TNGX) reported accrued manufacturing costs of $3.24M in Q1 2026.
How has Tango Therapeutics's accrued manufacturing costs changed year-over-year?: Tango Therapeutics's accrued manufacturing costs increased by 1.9% year-over-year, from $3.18M to $3.24M.
What is the long-term trend for Tango Therapeutics's accrued manufacturing costs?: Over 5 years (2020 to 2025), Tango Therapeutics's accrued manufacturing costs has grown at a 27.8% compound annual growth rate (CAGR), from $2.65M to $9.05M.